Searched for: in-biosketch:true
person:yannul01
Acquired vitelliform lesion associated with large drusen
Lima, Luiz H; Laud, Ketan; Freund, K Bailey; Yannuzzi, Lawrence A; Spaide, Richard F
PURPOSE: The purpose of this study was to describe the association of acquired vitelliform lesion (AVL) and large drusen in patients with non-neovascular age-related macular degeneration. METHODS: A retrospective review of clinical examination and multimodal imaging data of patients with AVL and large drusen seen over a 12-month period was performed. Acquired vitelliform lesion was defined as subretinal accretion of hyperautofluorescent yellowish material within the macular region not due to vitelliform macular dystrophy. Large drusen were diagnosed by the presence of mounded deposits in the subretinal pigment epithelial space between the retinal pigment epithelium and the Bruch membrane using multimodal imaging analysis (color photography, autofluorescence, and spectral domain optical coherence tomography). RESULTS: Thirteen eyes of 9 white patients with a mean age of 74 years were observed to have AVL associated with large drusen. The median visual acuity was 20/60. All AVLs were hyperautofluorescent and were located in the subretinal space between the retinal pigment epithelium and the photoreceptor inner segment/outer segment junction. The AVL in this series had similar color, autofluorescence, and optical coherence tomographic findings as the AVL seen in association with cuticular drusen and subretinal drusenoid deposits. CONCLUSION: Acquired vitelliform lesions, which have previously been related to cuticular drusen and subretinal drusenoid deposits, can occur in association with large drusen. Abnormalities leading to drusen formation or processes that function in parallel to these may be causative in AVL formation.
PMID: 22218150
ISSN: 0275-004x
CID: 543272
Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990 [Historical Article]
Yannuzzi, Lawrence A; Sorenson, John; Spaide, Richard F; Lipson, Barry
Eleven patients, 40 to 71 years old, had a choroidal vasculopathy that led to hemorrhagic and exudative macular degeneration. The patients had peculiar polypoidal, subretinal, vascular lesions associated with serous and hemorrhagic detachments of the retinal pigment epithelium. This macular disorder, which we have named idiopathic polypoidal choroidal vasculopathy (IPCV), appears to represent a distinct entity that differs clinically and demograph-ically from age-related macular degeneration (AMD) and other macular diseases associated with subretinal neovascularization. Recognition of this condition is important because it may have specific risk factors, natural course, and management considerations that differ from those of age-related macular degeneration
PMID: 22451948
ISSN: 0275-004x
CID: 543382
Unilateral acute idiopathic maculopathy. 1991 [Historical Article]
Yannuzzi, Lawrence A; Jampol, Lee M; Rabb, Maurice F; Sorenson, John A; Beyrer, Charles; Wilcox, Lloyd M Jr
This is a report of nine patients who experienced sudden, severe, unilateral central vision loss following a flulike illness. Each patient had an exudative detachment of the macula. All patients experienced a spontaneous resolution of the acute macular manifestations with near-complete recovery of vision. A characteristic "bull's-eye" appearance in the macula persisted. The acute manifestations of the disorder did not recur in any of the patients during the period of follow-up. The constellation of findings was suggestive of an inflammatory disease of the retinal pigment epithelium, but a specific causative agent could not be identified. The acute clinical and angiographic features, the natural course, and the residual pigment epithelial derangement were not consistent with any previously described disorder.
PMID: 22451959
ISSN: 0275-004x
CID: 543282
Idiopathic macular telangiectasia. 2006 [Historical Article]
Yannuzzi, Lawrence A; Bardal, Anne M C; Freund, K Bailey; Chen, Kuan-Jen; Eandi, Chiara M; Blodi, Barbara
OBJECTIVES: To review the frequency and nature of idiopathic macular telangiectasia and to classify the disorders based on new clinical and imaging observations. METHODS: A combined retrospective and prospective analysis of newly diagnosed patients seen over a period of 3 years. Patients were identified based on the Gass-Blodi classification and were studied with biomicroscopy, fluorescein angiography, and optical coherence tomography. RESULTS: Ten patients associated with aneurysmal telangiectasia (Gass-Blodi group 1) and 26 patients with perifoveal telangiectasia (Gass-Blodi group 2) were recruited. None with occlusive telangiectasia (Gass-Blodi group 3) were identified. New observations based on clinical, fluorescein angiographic, and optical coherence tomographic findings were made. CONCLUSIONS: Our series was similar to that in the Gass-Blodi study in terms of frequency. New observations in groups 1 and 2 have expanded our knowledge of the clinical spectrum of these disorders. A simplified classification termed idiopathic macular telangiectasia with 2 distinct types (type I, or aneurysmal telangiectasia, and type II, or perifoveal telangiectasia) was proposed to produce a better understanding of the entities and to enhance teaching and research. The third type, occlusive telangiectasia, has been omitted from our classification based on its rarity and presence of capillary nonperfusion rather than macular telangiectasia as the primary abnormality.
PMID: 22451954
ISSN: 0275-004x
CID: 543322
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. 2002 [Historical Article]
Spaide, Richard F; Donsoff, Irene; Lam, Deborah L; Yannuzzi, Lawrence A; Jampol, Lee M; Slakter, Jason; Sorenson, John; Freund, K Bailey
PURPOSE: To study the effects of photodynamic therapy using verteporfin in the treatment of patients with subfoveal polypoidal choroidal vasculopathy (PCV). METHODS: A retrospective chart review of 16 consecutive patients with subfoveal PCV treated with photodynamic therapy using verteporfin was performed. RESULTS: The mean age of the patients involved was 70.5 years. The mean follow-up time was 12 months. The visual acuity improved in 9 (56.3 %), remained the same in 5 (31.3 %), and decreased in 2 (12.5 %). The mean change in visual acuity was an improvement of 2.38 lines, a difference that was highly significant (P = 0.004). The change in visual acuity was negatively correlated with increasing age. The final visual acuity was positively correlated with initial acuity and negatively correlated with age. These results were confirmed by multiple linear regression. No patient had any lasting complication from the treatment. CONCLUSIONS: Subfoveal PCV has no proven method of treatment. Although the follow-up time and the number of patients in this pilot study were limited, the encouraging results and lack of complications suggest that further study is indicated.
PMID: 22451955
ISSN: 0275-004x
CID: 543312
Type A behavior and central serous chorioretinopathy [Historical Article]
Yannuzzi, Lawrence A
PMID: 22451956
ISSN: 0275-004x
CID: 543302
A classification of abnormal fundus fluorescence. 1971 [Historical Article]
Yannuzzi, Lawrence A; Flsher, Yale L; Levy, Jerome H
PMID: 22451957
ISSN: 0275-004x
CID: 543292
Recurrent subretinal neovascularization. 1987 [Historical Article]
Sorenson, John A; Yannuzzi, Lawrence A; Shakin, Jeffrey L
PMID: 22451958
ISSN: 0275-004x
CID: 543042
Krypton red laser photocoagulation of the ocular fundus. 1982 [Historical Article]
Yannuzzi, Lawrence A; Shakin, Jeffrey L
The theoretical rationale, the histopathologic evidence, and the preliminary clinical studies related to krypton red laser (KRL) photocoagulation of the ocular fundus are reviewed. The authors report on their experience with currently available laser systems using this wavelength (647.1 nm) for photocoagulation of retinal vascular proliferative diseases and chorioretinal diseases associated with exudative manifestations. A histopathologic and clinical comparison of argon blue-green laser (ABGL), the pure argon green laser (AGL), and the krypton yellow laser (KYL), with reference to photocoagulation treatment of the ocular fundus is also discussed.
PMID: 22451947
ISSN: 0275-004x
CID: 543052
Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? 1975 [Historical Article]
Schatz, Howard; Yannuzzi, Lawrence A; Gitter, Kurt A
The diagnosis of central serous chorioretinopathy is usually confirmed by the fluorescein angiographic finding of one or more pinpoint pigment epithelial leaks in or near a macula with a detached sensory retina. When argon laser photocoagulation is used to treat pigment epithelial leaks, resolution of the leaks occurs with reattachment of the sensory retina. We have seen six patients for whom a diagnosis of central serous chorioretinopathy was made; argon laser photocoagulation was carried out and subsequently followed by postoperative subretinal neovascularization often accompanied by hemorrhage, exudate and, in some cases, progressive reduction in visual acuity. Since the presentation of this paper to the American Academy of Ophthalmology and Otolaryngology in 1975, we have received photographs and case reports of 21 additional patients. This paper discusses these 27 cases and demonstrates the causes of the postoperative development of subretinal neovascularization
PMID: 22379619
ISSN: 0275-004x
CID: 543392